Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

ClinicalTrials.gov ID: NCT03541174

Public ClinicalTrials.gov record NCT03541174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center, Blinded, Randomized, Parallel-group, Phase 3 Study With Aprocitentan in Subjects With Resistant Hypertension (RHT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to other anti-hypertensive drugs of patients with difficult to control (resistant) high blood pressure (hypertension), and to show that blood pressure reduction is kept for long period of time.

Study identification

NCT ID
NCT03541174
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Idorsia Pharmaceuticals Ltd.
Industry
Enrollment
730 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2018 (Actual)
Primary completion
May 14, 2021 (Actual)
Completion
Apr 25, 2022 (Actual)
Last update posted
Mar 21, 2023

2018 – 2022

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Advanced Cardiovascular, LLC Alexander City Alabama 35010 —
Chrishard Medical Group Inglewood California 90301 —
Clinical Trials Research Lincoln California 95648 —
Academic Medical Research Institute Inc Los Angeles California 90022 —
Amicis Research Center Northridge California 91324 —
California Kidney Specialists San Dimas California 91773 —
Bay Area Cardiology Associates, P.A. Brandon Florida 33511 —
Century Clinical Research, Inc Daytona Beach Florida 32117 —
Mayo Clinic Jacksonville Jacksonville Florida 32224 —
Canvas Clinical Research, LLC Lake Worth Florida 33467 —
East Coast Institute for Research Saint Augustine Florida 32086 —
Premier Medical Associates The Villages Florida 32159 —
SIU School of Medicine Center for Clinical Research Springfield Illinois 62702 —
Midwest Institute for Clinical Research Indianapolis Indiana 46260 —
Cardiovascular Research of Northwest Indiana, L.L.C. Munster Indiana 46231 —
Reid Physician Associates Richmond Indiana 47374 —
Grace Research, LLC Bossier City Louisiana 71111 —
MedStar Health Research Institute Hyattsville Maryland 20782 —
Clinical Research Consultants, LLC Kansas City Missouri 64111 —
Hypertension and Nephrology Association PA Eatontown New Jersey 07724 —
Renal Medicine Associates Albuquerque New Mexico 87109 —
Albany Medical College Albany New York 12206 —
Scott Research Inc Laurelton New York 11413 —
Great Lakes Medical Research LLC Westfield New York 14787 —
Metrolina Internal Medicine/Internal Medicine Research Charlotte North Carolina 28207 —
East Carolina University Greenville North Carolina 27834 —
Physician's East Endocrinology Greenville North Carolina 27834 —
Carteret Medical Group Morehead City North Carolina 28557 —
University Hospitals Cleveland Medical Center - Neurological Institute Cleveland Ohio 44106 —
Willamette Valley Clinical Studies Eugene Oregon 97404 —
TLM Medical Services LLC Columbia South Carolina 29204 —
DeGarmo Institute of Medical Research Greer South Carolina 29650 —
Stern Cardiovascular Foundation, Inc Germantown Tennessee 38138 —
LifeDOC Research PLLC Memphis Tennessee 38119 —
Amarillo Heart Clinical Research Institute, Inc. Amarillo Texas 79106 —
LinQ Research, LLC Pearland Texas 77584 —
Mercury Clinical Research Webster Texas 77598 —
St. George Kidney Care LLC dba Southern Utah Kidney and Hypertension Center St. George Utah 84790 —
Burke Internal Medicine & Research Burke Virginia 22015 —
Manassas Clinical Research Center Manassas Virginia 20110 —
Milwaukee Nephrologists, SC Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 118 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03541174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03541174 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →